The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Open accessAbstract
The lack of therapy and the failure of existing therapy has been a challenge for clinicians in treating various cancers. Doxorubicin, 5-fluorouracil, cisplatin, and paclitaxel are the first-line therapy in various cancers; however, toxicity, resistance, and treatment failure limit their clinical use. Their status leads us to discover and investigate more targeted therapy with more efficacy. In this article, we dissect literature from the patient perspective, the tumor biology perspective, therapy-induced metastasis, and cell data generated in the laboratory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Cisplatin Nephrotoxicity: A Review
Yao, X., Panichpisal, K., Kurtzman, N., & Nugent, K. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31812dfe1e · Cited by 1,251
Hirano, T., Ishihara, K., & Hibi, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203551 · Cited by 1,190
Schoonjans, K., Peinado‐Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., & Auwerx, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00918.x · Cited by 1,173
Adriamycin: A New Anticancer Drug with Significant Clinical Activity
BLUM, R. H., & CARTER, S. K. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-2-249 · Cited by 1,057
Nguyen, M. T. A., Favelyukis, S., Nguyen, A.-K., Reichart, D., Scott, P. A., Jenn, A., Liu-Bryan, R., Glass, C. K., Neels, J. G., & Olefsky, J. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706762200 · Cited by 1,035
Environment-mediated drug resistance: A major contributor to minimal residual disease
Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2714 · Cited by 892
Doxorubicin-Induced Cardiomyopathy
Takemura, G., & Fujiwara, H. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.10.002 · Cited by 827
THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS
Rowinsky, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.353 · Cited by 721
Lemberger, T., Desvergne, B., & Wahli, W. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.335 · Cited by 712
Raf meets Ras: completing the framework of a signal transduction pathway
Avruch, J., Zhang, X.-F., & Kyriakis, J. M. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90005-1 · Cited by 577
Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M., & Hirano, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00734.x · Cited by 565
Sonis, S. T. (1998) · Oral Oncology · doi:10.1016/s1368-8375(97)00053-5 · Cited by 565
Yen, H. C., Oberley, T. D., Vichitbandha, S., Ho, Y. S., & St Clair, D. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118909 · Cited by 459
The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation
Tornatore, L., Thotakura, A. K., Bennett, J., Moretti, M., & Franzoso, G. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.001 · Cited by 447
Taxol (paclitaxel): mechanisms of action.
Horwitz, S. B. (1994) · PubMed · Cited by 434
Kajiyama, H., Shibata, K., Terauchi, M., Yamashita, M., Ino, K., Nawa, A., & Kikkawa, F. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.2.277 · Cited by 410
Ning, Y., Manegold, P. C., Hong, Y. K., Zhang, W., Pohl, A., Lurje, G., Winder, T., Yang, D., LaBonte, M. J., Wilson, P. M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25562 · Cited by 406
Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.
Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Glass, M., Burdick, M. D., & Strieter, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118734 · Cited by 403
Signaling mechanisms through gp130: A model of the cytokine system
Hirano, T., Nakajima, K., & Hibi, M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)80005-1 · Cited by 370
JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
Solinas, G., & Karin, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-151340 · Cited by 347
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy
Pusztai, L., Mendoza, T. R., Reuben, J. M., Martinez, M. M., Willey, J. S., Lara, J., Syed, A., Fritsche, H. A., Bruera, E., Booser, D., et al. (2004) · Cytokine · doi:10.1016/j.cyto.2003.10.004 · Cited by 312
Kang, Y. J., Chen, Y., & Epstein, P. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12610 · Cited by 303
The Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type 2 Diabetes
Cusi, K. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0122-6 · Cited by 300
NF-κB to the rescue: RELs, apoptosis and cellular transformation
Yin Foo, S., & Nolan, G. P. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(99)01719-9 · Cited by 279
Leong, C.-O., Vidnovic, N., DeYoung, M. P., Sgroi, D., & Ellisen, L. W. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30866 · Cited by 270
Latifi, A., Abubaker, K., Castrechini, N., Ward, A. C., Liongue, C., Dobill, F., Kumar, J., Thompson, E. W., Quinn, M. A., Findlay, J. K., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23199 · Cited by 243
Hayakawa, J., Ohmichi, M., Kurachi, H., Kanda, Y., Hisamoto, K., Nishio, Y., Adachi, K., Tasaka, K., Kanzaki, T., & Murata, Y. (2000) · PubMed · Cited by 243
Jo, S.-K., Cho, W. Y., Sung, S. A., Kim, H. K., & Won, N. H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67102.x · Cited by 235
Suppression of Apoptosis by Dominant Negative Mutants of Cyclin-dependent Protein Kinases
Meikrantz, W., & Schlegel, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.10205 · Cited by 234
Szajnik, M., Szczepanski, M. J., Czystowska, M., Elishaev, E., Mandapathil, M., Nowak-Markwitz, E., Spaczynski, M., & Whiteside, T. L. (2009) · Oncogene · doi:10.1038/onc.2009.289 · Cited by 226
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
Mabuchi, S., Ohmichi, M., Nishio, Y., Hayasaka, T., Kimura, A., Ohta, T., Saito, M., Kawagoe, J., Takahashi, K., Yada-Hashimoto, N., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313709200 · Cited by 211
Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance
Brozovic, A., & Osmak, M. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.10.007 · Cited by 204
Bandyopadhyay, A., Wang, L., Agyin, J., Tang, Y., Lin, S., Yeh, I.-T., De, K., & Sun, L.-Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010365 · Cited by 204
Lee, L.-F., Li, G., Templeton, D. J., & Ting, J. P.-Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28253 · Cited by 197
Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-α
Ramesh, G., & Reeves, W. B. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00413.x · Cited by 196
Sauter, K. A. D., Wood, L. J., Wong, J., Iordanov, M., & Magun, B. E. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.12.15540 · Cited by 194
Arjumand, W., Seth, A., & Sultana, S. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.05.012 · Cited by 177
IL-6-STAT3 signaling and premature senescence
Kojima, H., Inoue, T., Kunimoto, H., & Nakajima, K. (2013) · JAK-STAT · doi:10.4161/jkst.25763 · Cited by 170
Serum levels of NF-κB and pro-inflammatory cytokines following administration of mucotoxic drugs
M Logan, R., M Stringer, A., M Bowen, J., J Gibson, R., T Sonis, S., & M K Keefe, D. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.7.6207 · Cited by 168
Oakes, N. D., Thalén, P. G., Jacinto, S. M., & Ljung, B. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1158 · Cited by 168
Anderson, K. (2003) · European Journal of Haematology · doi:10.1034/j.1600-0609.2003.01067.x · Cited by 168
TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
Rajput, S., Volk-Draper, L. D., & Ran, S. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1019 · Cited by 165
Cordes, N., Seidler, J. F., Durzok, R., Geinitz, H., & Brakebusch, C. (2005) · Oncogene · doi:10.1038/sj.onc.1209164 · Cited by 164
Laplante, M., Sell, H., MacNaul, K. L., Richard, D., Berger, J. P., & Deshaies, Y. (2003) · Diabetes · doi:10.2337/diabetes.52.2.291 · Cited by 153
Shtil, A. A., Mandlekar, S., Yu, R., Walter, R. J., Hagen, K. L., Tan, T., Roninson, I. B., & Kong, A. T. (1999) · Oncogene · doi:10.1038/sj.onc.1202305 · Cited by 151
Nuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancer
Annunziata, C. M., Stavnes, H. T., Kleinberg, L., Berner, A., Hernandez, L. F., Birrer, M. J., Steinberg, S. M., Davidson, B., & Kohn, E. C. (2010) · Cancer · doi:10.1002/cncr.25190 · Cited by 145
Balachandran, V., Antony, J., Haritha, N. H., Puliyappadamba, V. T., Saikia, M., Narayanan, S. S., Bevin, A., & Anto, R. J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.26 · Cited by 142
CXC‐chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer
Matsuo, Y., Raimondo, M., Woodward, T. A., Wallace, M. B., Gill, K. R., Tong, Z., Burdick, M. D., Yang, Z., Strieter, R. M., Hoffman, R. M., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24383 · Cited by 140
Kortylewski, M., Heinrich, P. C., Mackiewicz, A. A., Schniertshauer, U., Klingmüller, U., Nakajima, K., Hirano, T., Horn, F., & Behrmann, I. (1999) · Oncogene · doi:10.1038/sj.onc.1202708 · Cited by 135
Jiang, C., Ganther, H. E., & Lü, J. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200012)29:4<219::aid-mc1004>3.0.co;2-d · Cited by 131
Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma
Bisping, G., Leo, R., Wenning, D., Dankbar, B., Padró, T., Kropff, M. H., Scheffold, C., Kröger, M., Mesters, R. M., Berdel, W. E., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2907 · Cited by 127
Domitrović, R., Cvijanović, O., Pugel, E. P., Zagorac, G. B., Mahmutefendić, H., & Škoda, M. (2013) · Toxicology · doi:10.1016/j.tox.2013.05.015 · Cited by 124
Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage
Bowen, J. M., Gibson, R. J., Cummins, A. G., & Keefe, D. M. K. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-005-0004-7 · Cited by 119
Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
Iliskovic, N., & Singal, P. K. (1997) · Europe PMC (PubMed Central) · Cited by 114
Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy
Guerrero-Beltrán, C. E., Mukhopadhyay, P., Horváth, B., Rajesh, M., Tapia, E., García‐Torres, I., Pedraza‐Chaverrí, J., & Pacher, P. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.02.004 · Cited by 107
Zaks‐Zilberman, M., Zaks, T. Z., & Vogel, S. N. (2001) · Cytokine · doi:10.1006/cyto.2001.0935 · Cited by 106
Jiang, G., Dallas-Yang, Q., Li, Z., Szalkowski, D., Liu, F., Shen, X., Wu, M. S., Zhou, G., Doebber, T. W., Berger, J., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2412 · Cited by 106
Zhuo, W., Wang, Y., Zhuo, X.-L., Zhang, Y., & Chen, Z. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.143 · Cited by 99
Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury
Mukhopadhyay, P., Horváth, B., Kechrid, M., Tanchian, G., Rajesh, M., Naura, A. S., Boulares, A. H., & Pacher, P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.006 · Cited by 97
Ohta, T., Ohmichi, M., Hayasaka, T., Mabuchi, S., Saitoh, M., Kawagoe, J., Takahashi, K., Igarashi, H., Du, B., Doshida, M., et al. (2006) · Endocrinology · doi:10.1210/en.2005-1450 · Cited by 94
Arunachalam, S., Pichiah, P. B. T., & Achiraman, S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.11.019 · Cited by 90
Lee, L., Haskill, J. S., Mukaida, N., Matsushima, K., & Ting, J. P. ‐. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5097 · Cited by 88
Zhu, J., Zhang, J., Xiang, D., Zhang, Z., Zhang, L., Wu, M., Zhu, S., Zhang, R., & Han, W. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.024 · Cited by 86
Paclitaxel Binding to Human and Murine MD-2
Zimmer, S. M., Liu, J., Clayton, J. L., Stephens, D. S., & Snyder, J. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802826200 · Cited by 85
Collins, T. S., Lee, L., & Ting, J. P. ‐. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050605 · Cited by 82
Volk, L. D., Flister, M. J., Bivens, C., Stutzman, A., Desai, N. P., Trieu, V. N., & Ran, S. (2008) · Neoplasia · doi:10.1593/neo.08302 · Cited by 78
PPARγ activation induces CD36 expression and stimulates foam cell like changes in rVSMCs
Lim, H., Lee, S., Lee, K., Park, J., Jang, Y., Lee, E. J., & Park, H. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.06.006 · Cited by 74
Elsea, C. R., Roberts, D. A., Druker, B. J., & Wood, L. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002355 · Cited by 71
White, C. M., Martin, B. K., Lee, L., Haskill, J. S., & Ting, J. P. ‐. (1998) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050468 · Cited by 69
Uchibori, K., Kasamatsu, A., Sunaga, M., et al. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1300 · Cited by 65
Xu, R., Sato, N., Yanai, K., Akiyoshi, T., Nagai, S., 和田, 純., Koga, K., Mibu, R., Nakamura, M., & Katano, M. (2009) · PubMed · Cited by 62
Induction of TNF-?, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells
Niiya, M., Niiya, K., Kiguchi, T., Shibakura, M., Asaumi, N., Shinagawa, K., Ishimaru, F., Kiura, K., Ikeda, K., Ueoka, H., et al. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0665-1 · Cited by 54
Pei, Z., Lin, D., Song, X., Li, H., & Yao, H. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2008.06.007 · Cited by 54
Expression and Functional Research of TLR4 in Human Colon Carcinoma
Tang, X., Wang, H., Zhu, Y., & Wei, B. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181cef1b7 · Cited by 52
Nadhanan, R. R., Mashtoub, S., Su, Y., Scherer, M. A., Howarth, G. S., & Xian, C. J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00587.2011 · Cited by 49
Moos, P. J., Muskardin, D. T., & Fitzpatrick, F. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.467 · Cited by 43
Lee, S., Yoon, S., & Kim, D. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.08.040 · Cited by 41
Cisplatin regulates Sertoli cell expression of transferrin and interleukins
Yamaguchi, K., Ishikawa, T., Kondo, Y., & Fujisawa, M. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.11.021 · Cited by 39
Bisping, G., Wenning, D., Kropff, M. H., Gustavus, D., Müller‐Tidow, C., Stelljes, M., Munzert, G. M., Hilberg, F., Roth, G. J., Štefanič, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1612 · Cited by 33
Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer.
Reers, S., Pfannerstill, A.-C., Rades, D., Maushagen, R., Andratschke, M., Pries, R., & Wollenberg, B. (2013) · PubMed · Cited by 33
Signaling from p53 to NF-κB Determines the Chemotherapy Responsiveness of Neuroblastoma
Armstrong, M. B., Bian, X., Liu, Y., Subramanian, C., Ratanaproeksa, A. B., Shao, F., Yu, V. C. K., Kwok, R. P. S., Opipari, A. W., & Castle, V. P. (2006) · Neoplasia · doi:10.1593/neo.06574 · Cited by 31
Shibakura, M., Niiya, K., Kiguchi, T., Kitajima, I., Niiya, M., Asaumi, N., Huh, N., Nakata, Y., Harada, M., & Tanimoto, M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10842 · Cited by 25
Cited by
Lian, M. Q., Chng, W. H., Liang, J., Yeo, H. Q., Lee, C. K., Belaid, M., Tollemeto, M., Wacker, M. G., Czarny, B., & Pastorin, G. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12283 · Cited by 388
Stress and cancer: mechanisms, significance and future directions
Eckerling, A., Ricon-Becker, I., Sorski, L., Sandbank, E., & Ben-Eliyahu, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00395-5 · Cited by 348
Caiado, F., Pietras, E. M., & Manz, M. G. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201541 · Cited by 289
Mousset, A., Lecorgne, E., Bourget, I., Lopez, P., Jenovai, K., Cherfils-Vicini, J., Dominici, C., Rios, G., Girard-Riboulleau, C., Liu, B., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.03.008 · Cited by 266
Liu, Y.-Q., Wang, X.-L., He, D.-H., & Cheng, Y.-X. (2021) · Phytomedicine · doi:10.1016/j.phymed.2020.153402 · Cited by 259
Metadata
- Authors
- Vyas, D., Laput, G., & Vyas, A.
- Venue
- OncoTargets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2014-06
- Volume
- 7
- Pages
- 1015
- ISSN
- 1178-6930 (ISSN-L)
- OpenAlex
- W2065443310
- Cited by
- 310
- References
- 89
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.